Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Toumaz Names Dr Ian McWalter As New CEO

Toumaz Technology Limited Names Dr Ian McWalter As New CEO

Abingdon, United Kingdom | Posted on April 27, 2006

Toumaz Technology Limited today announces that it has appointed Dr Ian Lindsay McWalter as its new Chief Executive Officer. Keith Errey, who served as Toumaz CEO since co-founding the company in 2000, will take on the role of Chief Operating Officer (COO).

Dr McWalter was most recently President and CEO of Canadian semiconductor manufacturer Gennum Corporation, and brings to his new role over 30 years of experience in the semiconductor and electronics industry ­ 20 of those gained in senior management positions at Gennum and Nortel.

Dr McWalter joins Toumaz with a focus on accelerating the commercialisation of Toumaz’s proprietary AMx™ advanced mixed signal technology within its key healthcare and consumer electronic markets. Following its acquisition in November 2005 by AIM-listed nanotechnology investment vehicle Nanoscience Inc., Toumaz announced plans to invest in a number of key areas, including ongoing development of new products and the ultra-low power Sensium™ family of devices, investigations into advanced semiconductor processes and the strengthening of the company’s engineering and commercial teams.

Richard Rose, Non-Executive Chairman of Nanoscience, said, "We are extremely pleased with the appointment of Dr. McWalter to the role of CEO at Toumaz Technology. With his wealth of industry experience and strong track record in commercialising semiconductor technology, I believe Dr McWalter is ideally suited to lead Toumaz’s development into a revenue-generating commercial supplier of ultra-low power integrated circuits and silicon chip solutions.”

Commenting on his appointment, Dr McWalter added, “Toumaz’s leadership in ultra-low power silicon for wireless and signal processing applications is enabling truly revolutionary products in the industry’s major markets ­ including healthcare and consumer electronics ­ and I am delighted to be joining a team with such exciting commercial potential.”

Dr McWalter gained his Ph.D in Electrical Engineering from Imperial College in 1976 and has held board positions with a number of electronics companies and key industry bodies.

####

About Toumaz Technology Limited:
Toumaz Technology Limited is a developer of advanced RF, analogue and mixed signal semiconductors. The focus of the business is low power devices based on the company’s proprietary AMx™ (Advanced Mixed Signal) technology which addresses the needs of lower power consumption for mobile and wirelessly connected systems.

For more information, please click here.

Contact:
Nicky Davis
(EvokedSet PR for Toumaz)
+44 (0) 7747 017654
nicky@evokedset.com

Copyright © Toumaz Technology Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

GLOBALFOUNDRIES and Chengdu Partner to Expand FD-SOI Ecosystem in China: More than $100M investment to establish a center of excellence for FDXTM FD-SOI design May 23rd, 2017

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

Leti Will Demo World’s-first WVGA 10-µm Pitch GaN Microdisplays for Augmented Reality Video at Display Week in Los Angles: Invited Paper also Will Present Leti’s Success with New Augmented Reality Technology That Reduces Pixel Pitch to Less than 5 Microns May 22nd, 2017

Graphene-nanotube hybrid boosts lithium metal batteries: Rice University prototypes store 3 times the energy of lithium-ion batteries May 19th, 2017

Appointments/Promotions/New hires/Resignations/Deaths

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project